Sector
PharmaceuticalsOpen
₹597.4Prev. Close
₹580Turnover(Lac.)
₹71.59Day's High
₹597.4Day's Low
₹56052 Week's High
₹64552 Week's Low
₹253.45Book Value
₹155.43Face Value
₹10Mkt Cap (₹ Cr.)
488.3P/E
20.25EPS
28.64Divi. Yield
018 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
29 May 2023
12:00 AM
Dividend
Dividend Amount: 1.8
Record Date: 22 Sep, 2023
1 Sep 2023
12:00 AM
AGM
Announcement Date: 01 Sep, 2023
1 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 8.26 | 8.26 | 8.26 | 8.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 97.83 | 77.98 | 57.56 | 29.55 |
Net Worth | 106.09 | 86.24 | 65.82 | 37.81 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 122.45 | 69.47 | 55.53 | 52.45 |
yoy growth (%) | 76.26 | 25.11 | 5.86 | 14.99 |
Raw materials | -53.31 | -36.08 | -32.29 | -33.97 |
As % of sales | 43.53 | 51.94 | 58.15 | 64.76 |
Employee costs | -12.04 | -10.02 | -3.07 | -2.76 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 39.08 | 7.62 | 3.91 | 3.49 |
Depreciation | -2.1 | -1.74 | -0.9 | -0.79 |
Tax paid | -9.98 | -2.04 | -1.07 | -1.15 |
Working capital | 11.11 | 5.04 | 2.13 | 6.97 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 76.26 | 25.11 | 5.86 | 14.99 |
Op profit growth | 284.77 | 62.05 | 21.72 | 40.81 |
EBIT growth | 323.54 | 51.95 | 26.47 | 38.72 |
Net profit growth | 363.96 | 118.42 | 21.51 | 35.56 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 164.07 | 144 | 152.81 | 142.24 | 79.44 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 164.07 | 144 | 152.81 | 142.24 | 79.44 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.75 | 1.94 | 1.02 | 0.79 | 1.06 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,587.9 | 124.83 | 3,80,990.4 | 867.6 | 0.85 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,534.75 | 76.42 | 1,20,383.36 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,489.7 | 32.38 | 1,20,295.96 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,154.4 | 33.79 | 1,16,159.65 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,769.25 | 26.36 | 1,12,931.2 | 1,034.8 | 0.59 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Naresh Kumar Singla
Managing Director
Suresh Chand Singla
Non-Exec & Non-Independent Dir
Manju Singla
Company Sec. & Compli. Officer
Charanjit Singh
Non-Exec & Non-Independent Dir
Supriya Singla
Non-Exec. & Independent Dir.
Rekha Dalmia
Chairman & Independent Directo
Rohit Jain
Independent Director
Abhishek Agarwal
Whole-time Director
Raja Singla
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Titan Biotech Ltd
Summary
Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities.The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals souced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.During 2006-07, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 2009-10.
Read More
What is the Titan Biotech Ltd share price today?
The Titan Biotech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹590.9 today.
What is the Market Cap of Titan Biotech Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Titan Biotech Ltd is ₹488.30 Cr. as of 23 Jul ‘24
What is the PE and PB ratio of Titan Biotech Ltd?
The PE and PB ratios of Titan Biotech Ltd is 20.25 and 3.73 as of 23 Jul ‘24
What is the 52 Week High and Low of Titan Biotech Ltd?
The 52-week high/low is the highest and lowest price at which a Titan Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Titan Biotech Ltd is ₹253.45 and ₹645 as of 23 Jul ‘24
What is the CAGR of Titan Biotech Ltd?
Titan Biotech Ltd's CAGR for 5 Years at 70.55%, 3 Years at 19.11%, 1 Year at 126.21%, 6 Month at 21.66%, 3 Month at 15.71% and 1 Month at 0.86%.
What is the shareholding pattern of Titan Biotech Ltd?
The shareholding pattern of Titan Biotech Ltd is as follows:
Promoters - 55.88 %
Institutions - 0.00 %
Public - 44.12 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
